Review





Similar Products

compounds 1 4 against hepg2  (ATCC)
99
ATCC compounds 1 4 against hepg2
Compounds 1 4 Against Hepg2, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/compounds 1 4 against hepg2/product/ATCC
Average 99 stars, based on 1 article reviews
compounds 1 4 against hepg2 - by Bioz Stars, 2026-05
99/100 stars
  Buy from Supplier
certified reference materials  (LGC Standards)
94
LGC Standards certified reference materials
Certified Reference Materials, supplied by LGC Standards, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/certified reference materials/product/LGC Standards
Average 94 stars, based on 1 article reviews
certified reference materials - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier
molecule compound rcm1 2 2 oxo 2 thiophen 2 yl ethyl sulfanyl 4 6 di thiophen 2 yl pyridine 3 carbonitrile  (Vitas-M Laboratory Ltd)
86
Vitas-M Laboratory Ltd molecule compound rcm1 2 2 oxo 2 thiophen 2 yl ethyl sulfanyl 4 6 di thiophen 2 yl pyridine 3 carbonitrile
The combination of <t>RCM1-NP</t> FA and venetoclax decreases tumor growth and enhances caspase-mediated apoptosis in a murine RMS model. (A) Schematic diagram of tumor cells inoculation and treatment. The figure is created in BioRender. Merjaneh, N. (2024) https://BioRender.com/z67t342 . (B) Combination therapy significantly reduced tumor burden compared with vehicle. The mean vehicle tumor volume on day 21 was 685 mm 3 , compared with the average tumor volume of the combination therapy of 361 mm 3 . The maximum tumor diameter was 17.3×11.5 mm and the corresponding maximum tumor volume was 1,144 mm 3 . Tumor volume was measured at different time points during the experiment (P≤0.01; n=12). (C) Combination therapy inhibited proliferation, as indicated by the decreased number of Ki67-positive cells. Combination therapy increased apoptosis, shown by the increased number of (D) BAX-positive cells and (E) the number of caspase3-positive cells compared with single agents and/or vehicle. A total of five random fields per sample were used to quantify the number of Ki67, BAX and cleaved caspase 3 positive cells per group. Values are shown as mean ± SD. Scale bar, 10 μ m. * P≤0.05, ** P≤0.01, **** P≤0.0001. RMS, rhabdomyosarcoma.
Molecule Compound Rcm1 2 2 Oxo 2 Thiophen 2 Yl Ethyl Sulfanyl 4 6 Di Thiophen 2 Yl Pyridine 3 Carbonitrile, supplied by Vitas-M Laboratory Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/molecule compound rcm1 2 2 oxo 2 thiophen 2 yl ethyl sulfanyl 4 6 di thiophen 2 yl pyridine 3 carbonitrile/product/Vitas-M Laboratory Ltd
Average 86 stars, based on 1 article reviews
molecule compound rcm1 2 2 oxo 2 thiophen 2 yl ethyl sulfanyl 4 6 di thiophen 2 yl pyridine 3 carbonitrile - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier
ethylphenyl methylene 2 thioxo 4 thiazolidinone compound 10058 f4 tocris bioscience  (Tocris)
93
Tocris ethylphenyl methylene 2 thioxo 4 thiazolidinone compound 10058 f4 tocris bioscience
The combination of <t>RCM1-NP</t> FA and venetoclax decreases tumor growth and enhances caspase-mediated apoptosis in a murine RMS model. (A) Schematic diagram of tumor cells inoculation and treatment. The figure is created in BioRender. Merjaneh, N. (2024) https://BioRender.com/z67t342 . (B) Combination therapy significantly reduced tumor burden compared with vehicle. The mean vehicle tumor volume on day 21 was 685 mm 3 , compared with the average tumor volume of the combination therapy of 361 mm 3 . The maximum tumor diameter was 17.3×11.5 mm and the corresponding maximum tumor volume was 1,144 mm 3 . Tumor volume was measured at different time points during the experiment (P≤0.01; n=12). (C) Combination therapy inhibited proliferation, as indicated by the decreased number of Ki67-positive cells. Combination therapy increased apoptosis, shown by the increased number of (D) BAX-positive cells and (E) the number of caspase3-positive cells compared with single agents and/or vehicle. A total of five random fields per sample were used to quantify the number of Ki67, BAX and cleaved caspase 3 positive cells per group. Values are shown as mean ± SD. Scale bar, 10 μ m. * P≤0.05, ** P≤0.01, **** P≤0.0001. RMS, rhabdomyosarcoma.
Ethylphenyl Methylene 2 Thioxo 4 Thiazolidinone Compound 10058 F4 Tocris Bioscience, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ethylphenyl methylene 2 thioxo 4 thiazolidinone compound 10058 f4 tocris bioscience/product/Tocris
Average 93 stars, based on 1 article reviews
ethylphenyl methylene 2 thioxo 4 thiazolidinone compound 10058 f4 tocris bioscience - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier
compound 4  (MedChemExpress)
94
MedChemExpress compound 4
The combination of <t>RCM1-NP</t> FA and venetoclax decreases tumor growth and enhances caspase-mediated apoptosis in a murine RMS model. (A) Schematic diagram of tumor cells inoculation and treatment. The figure is created in BioRender. Merjaneh, N. (2024) https://BioRender.com/z67t342 . (B) Combination therapy significantly reduced tumor burden compared with vehicle. The mean vehicle tumor volume on day 21 was 685 mm 3 , compared with the average tumor volume of the combination therapy of 361 mm 3 . The maximum tumor diameter was 17.3×11.5 mm and the corresponding maximum tumor volume was 1,144 mm 3 . Tumor volume was measured at different time points during the experiment (P≤0.01; n=12). (C) Combination therapy inhibited proliferation, as indicated by the decreased number of Ki67-positive cells. Combination therapy increased apoptosis, shown by the increased number of (D) BAX-positive cells and (E) the number of caspase3-positive cells compared with single agents and/or vehicle. A total of five random fields per sample were used to quantify the number of Ki67, BAX and cleaved caspase 3 positive cells per group. Values are shown as mean ± SD. Scale bar, 10 μ m. * P≤0.05, ** P≤0.01, **** P≤0.0001. RMS, rhabdomyosarcoma.
Compound 4, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/compound 4/product/MedChemExpress
Average 94 stars, based on 1 article reviews
compound 4 - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier
compound 4  (Combi-Blocks Inc)
86
Combi-Blocks Inc compound 4
The combination of <t>RCM1-NP</t> FA and venetoclax decreases tumor growth and enhances caspase-mediated apoptosis in a murine RMS model. (A) Schematic diagram of tumor cells inoculation and treatment. The figure is created in BioRender. Merjaneh, N. (2024) https://BioRender.com/z67t342 . (B) Combination therapy significantly reduced tumor burden compared with vehicle. The mean vehicle tumor volume on day 21 was 685 mm 3 , compared with the average tumor volume of the combination therapy of 361 mm 3 . The maximum tumor diameter was 17.3×11.5 mm and the corresponding maximum tumor volume was 1,144 mm 3 . Tumor volume was measured at different time points during the experiment (P≤0.01; n=12). (C) Combination therapy inhibited proliferation, as indicated by the decreased number of Ki67-positive cells. Combination therapy increased apoptosis, shown by the increased number of (D) BAX-positive cells and (E) the number of caspase3-positive cells compared with single agents and/or vehicle. A total of five random fields per sample were used to quantify the number of Ki67, BAX and cleaved caspase 3 positive cells per group. Values are shown as mean ± SD. Scale bar, 10 μ m. * P≤0.05, ** P≤0.01, **** P≤0.0001. RMS, rhabdomyosarcoma.
Compound 4, supplied by Combi-Blocks Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/compound 4/product/Combi-Blocks Inc
Average 86 stars, based on 1 article reviews
compound 4 - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier
compound 4 octyl itaconate  (MedChemExpress)
95
MedChemExpress compound 4 octyl itaconate
Nrf2 pathway and oxidative stress were associated with IRG1/itaconate in acute myocardial injury. WT or IRG1 KO mice with acute myocardial injury were supplemented <t>with</t> <t>4-octyl</t> itaconate (4-OI) and sacrificed 18 h post LPS exposure. ( A – D ) The levels of ROS, TBARS, the GSSG/GSH ratioin cardiac tissue homogenates and serum 8-OH-dG concentration were quantified ( n = 8). ( E , F ) Representative western blots and statistical analysis of IL-1β, NLRP3, Keap1, Nrf2, HO-1 and NQO1in heart samples were displayed ( n = 4). Data are representative of two independent experiments and show mean ± SD. ( A – D ) Two-way ANOVA with Sidak multiple comparison test. ( F ) two-sided t -test.
Compound 4 Octyl Itaconate, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/compound 4 octyl itaconate/product/MedChemExpress
Average 95 stars, based on 1 article reviews
compound 4 octyl itaconate - by Bioz Stars, 2026-05
95/100 stars
  Buy from Supplier
compound 4 binding  (Molecular Dynamics Inc)
86
Molecular Dynamics Inc compound 4 binding
Nrf2 pathway and oxidative stress were associated with IRG1/itaconate in acute myocardial injury. WT or IRG1 KO mice with acute myocardial injury were supplemented <t>with</t> <t>4-octyl</t> itaconate (4-OI) and sacrificed 18 h post LPS exposure. ( A – D ) The levels of ROS, TBARS, the GSSG/GSH ratioin cardiac tissue homogenates and serum 8-OH-dG concentration were quantified ( n = 8). ( E , F ) Representative western blots and statistical analysis of IL-1β, NLRP3, Keap1, Nrf2, HO-1 and NQO1in heart samples were displayed ( n = 4). Data are representative of two independent experiments and show mean ± SD. ( A – D ) Two-way ANOVA with Sidak multiple comparison test. ( F ) two-sided t -test.
Compound 4 Binding, supplied by Molecular Dynamics Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/compound 4 binding/product/Molecular Dynamics Inc
Average 86 stars, based on 1 article reviews
compound 4 binding - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier

Image Search Results


The combination of RCM1-NP FA and venetoclax decreases tumor growth and enhances caspase-mediated apoptosis in a murine RMS model. (A) Schematic diagram of tumor cells inoculation and treatment. The figure is created in BioRender. Merjaneh, N. (2024) https://BioRender.com/z67t342 . (B) Combination therapy significantly reduced tumor burden compared with vehicle. The mean vehicle tumor volume on day 21 was 685 mm 3 , compared with the average tumor volume of the combination therapy of 361 mm 3 . The maximum tumor diameter was 17.3×11.5 mm and the corresponding maximum tumor volume was 1,144 mm 3 . Tumor volume was measured at different time points during the experiment (P≤0.01; n=12). (C) Combination therapy inhibited proliferation, as indicated by the decreased number of Ki67-positive cells. Combination therapy increased apoptosis, shown by the increased number of (D) BAX-positive cells and (E) the number of caspase3-positive cells compared with single agents and/or vehicle. A total of five random fields per sample were used to quantify the number of Ki67, BAX and cleaved caspase 3 positive cells per group. Values are shown as mean ± SD. Scale bar, 10 μ m. * P≤0.05, ** P≤0.01, **** P≤0.0001. RMS, rhabdomyosarcoma.

Journal: International Journal of Oncology

Article Title: FOXM1 inhibitor, RCM-1, enhances venetoclax mediated apoptosis through downregulation of ATP2B4 in rhabdomyosarcoma

doi: 10.3892/ijo.2026.5865

Figure Lengend Snippet: The combination of RCM1-NP FA and venetoclax decreases tumor growth and enhances caspase-mediated apoptosis in a murine RMS model. (A) Schematic diagram of tumor cells inoculation and treatment. The figure is created in BioRender. Merjaneh, N. (2024) https://BioRender.com/z67t342 . (B) Combination therapy significantly reduced tumor burden compared with vehicle. The mean vehicle tumor volume on day 21 was 685 mm 3 , compared with the average tumor volume of the combination therapy of 361 mm 3 . The maximum tumor diameter was 17.3×11.5 mm and the corresponding maximum tumor volume was 1,144 mm 3 . Tumor volume was measured at different time points during the experiment (P≤0.01; n=12). (C) Combination therapy inhibited proliferation, as indicated by the decreased number of Ki67-positive cells. Combination therapy increased apoptosis, shown by the increased number of (D) BAX-positive cells and (E) the number of caspase3-positive cells compared with single agents and/or vehicle. A total of five random fields per sample were used to quantify the number of Ki67, BAX and cleaved caspase 3 positive cells per group. Values are shown as mean ± SD. Scale bar, 10 μ m. * P≤0.05, ** P≤0.01, **** P≤0.0001. RMS, rhabdomyosarcoma.

Article Snippet: The small molecule compound RCM1 (2-[2-oxo-2-(thiophen-2-yl) ethyl]sulfanyl-4,6-di(thiophen-2-yl) pyridine-3-carbonitrile) was synthesized by Vitas-M Laboratory (95% purity) and dissolved in DMSO for in vitro studies.

Techniques:

Nrf2 pathway and oxidative stress were associated with IRG1/itaconate in acute myocardial injury. WT or IRG1 KO mice with acute myocardial injury were supplemented with 4-octyl itaconate (4-OI) and sacrificed 18 h post LPS exposure. ( A – D ) The levels of ROS, TBARS, the GSSG/GSH ratioin cardiac tissue homogenates and serum 8-OH-dG concentration were quantified ( n = 8). ( E , F ) Representative western blots and statistical analysis of IL-1β, NLRP3, Keap1, Nrf2, HO-1 and NQO1in heart samples were displayed ( n = 4). Data are representative of two independent experiments and show mean ± SD. ( A – D ) Two-way ANOVA with Sidak multiple comparison test. ( F ) two-sided t -test.

Journal: Scientific Reports

Article Title: Protective role of IRG1/itaconate in acute myocardial injury: association with NLRP3 inflammasome and oxidative stress

doi: 10.1038/s41598-026-43821-0

Figure Lengend Snippet: Nrf2 pathway and oxidative stress were associated with IRG1/itaconate in acute myocardial injury. WT or IRG1 KO mice with acute myocardial injury were supplemented with 4-octyl itaconate (4-OI) and sacrificed 18 h post LPS exposure. ( A – D ) The levels of ROS, TBARS, the GSSG/GSH ratioin cardiac tissue homogenates and serum 8-OH-dG concentration were quantified ( n = 8). ( E , F ) Representative western blots and statistical analysis of IL-1β, NLRP3, Keap1, Nrf2, HO-1 and NQO1in heart samples were displayed ( n = 4). Data are representative of two independent experiments and show mean ± SD. ( A – D ) Two-way ANOVA with Sidak multiple comparison test. ( F ) two-sided t -test.

Article Snippet: The compound 4-Octyl itaconate (4-OI, #HY-112675) was sourced from MedChemExpress, USA.

Techniques: Concentration Assay, Western Blot, Comparison